Efficacy and Safety of Once-Weekly Semaglutide vs. Exenatide ER in Subjects with Type 2 Diabetes (SUSTAIN 3)Andrew J. Ahmann,Matthew Capehorn,Guillaume Charpentier,Francesco Dotta,Elena Henkel,Ildiko Lingvay,Anders Gaarsdal Holst, Denise Chang,Vanita R. ArodaDIABETES(2016)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要